Full Text View
Tabular View
No Study Results Posted
Related Studies
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
This study has been completed.
Study NCT00336856   Information provided by University of Pittsburgh

First Received on June 12, 2006.   Last Updated on December 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial